IAMA Therapeutics Alternatives & Competitors
12 companies similar to IAMA Therapeutics — Our mission is to make a difference in the lives of individuals suffering from n...
Companies similar to IAMA Therapeutics
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
United Kingdom
iOnctura
Developing precision small molecules to combat hard-to-treat tumors.
Geneve, Switzerland
Prilenia
Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopment...
Boston, United States
PaxMedica, Inc.
Empowering Possibilities, Transforming Lives: PaxMedica's Journey in Neurodevelopmental So...
Tarrytown, United States
Rival Readout
Competing with IAMA Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
MacuCLEAR
Pioneering innovative treatments for vascular eye disorders with promising clinical succes...
Addex Therapeutics
Allosteric modulators for Human Health
Plan-les-ouates, Switzerl...
Seaport Therapeutics
We are a clinical-stage therapeutics company advancing the development of novel neuropsych...
Boston, United States
Gate Neurosciences
Brain Health, Reimagined
Indianapolis, United Stat...
Biscayne Neurotherapeutics Inc
A clinical-stage biotechnology company advancing innovative therapies for challenging neur...
Miami, United States
Cerebral Therapeutics, Inc.
A clinical stage pharmaceutical company developing innovative treatments for neurological...
Aurora, United States
Wize Pharma
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment o...
Hod Hasharon, Israel
Adastra Pharmaceuticals
Adastra is committed to transforming cancer care.
Princeton, United States
About IAMA Therapeutics
IAMA Therapeutics is a biotechnology and pharmaceutical company based in Italy, with a mission to address the unmet medical needs of individuals suffering from neurodevelopmental and cognitive disorders. Recently, the company raised a Series A investment of $8.80M from CDP Equity in January 2022. The company, founded i...
Clinical-stage Pharmaceutical, Neurodevelopmental Disorders, Epilepsy, Neuropsychiatric Conditions, Cation Chloride Cotransporters, Drug Development, Series B Funding, Clinical Trial, NKCC1 Inhibitor, Pediatric Medicine
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around IAMA Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at IAMA Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
